Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reference pricing with evidence development: a way forward for proton therapy.

Literature DB >> 24752049

Reference pricing with evidence development: a way forward for proton therapy.

Justin E Bekelman¹, Stephen M Hahn².

Abstract

Mesh：

Year: 2014 PMID： 24752049 PMCID： PMC4026577 DOI： 10.1200/JCO.2014.55.6613

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

× No keyword cloud information.

8 in total

1. Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer.

Authors: H Gilbert Welch; Juliana Mogielnicki
Journal: BMJ Date: 2002-05-04

2. How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursement.

Authors: Steven D Pearson; Peter B Bach
Journal: Health Aff (Millwood) Date: 2010-10 Impact factor: 6.301

3. Coverage options for promising technologies: Medicare's 'coverage with evidence development'.

Authors: Sean R Tunis; Steven D Pearson
Journal: Health Aff (Millwood) Date: 2006 Sep-Oct Impact factor: 6.301

4. Medicare's requirement for research participation as a condition of coverage: is it ethical?

Authors: Steven D Pearson; Franklin G Miller; Ezekiel J Emanuel
Journal: JAMA Date: 2006-08-23 Impact factor: 56.272

5. De Testimonio: on the evidence for decisions about the use of therapeutic interventions.

Authors: Michael Rawlins
Journal: Clin Med (Lond) Date: 2008-12 Impact factor: 2.659

6. Position statement on ethics, equipoise and research on charged particle radiation therapy.

Authors: Mark Sheehan; Claire Timlin; Ken Peach; Ariella Binik; Wilson Puthenparampil; Mark Lodge; Sean Kehoe; Michael Brada; Neil Burnet; Steve Clarke; Adrian Crellin; Michael Dunn; Piero Fossati; Steve Harris; Michael Hocken; Tony Hope; Jonathan Ives; Tadashi Kamada; Alex John London; Robert Miller; Michael Parker; Madelon Pijls-Johannesma; Julian Savulescu; Susan Short; Loane Skene; Hirohiko Tsujii; Jeffrey Tuan; Charles Weijer
Journal: J Med Ethics Date: 2013-09-17 Impact factor: 2.903

7. Access with evidence development: the US experience.

Authors: Penny E Mohr; Sean R Tunis
Journal: Pharmacoeconomics Date: 2010 Impact factor: 4.981

8. Insurance coverage for experimental technologies.

Authors: E P Steinberg; S Tunis; D Shapiro
Journal: Health Aff (Millwood) Date: 1995 Impact factor: 6.301

8 in total

13 in total

1. Randomized Trials of Proton Therapy: Why They Are at Risk, Proposed Solutions, and Implications for Evaluating Advanced Technologies to Diagnose and Treat Cancer.

Authors: Justin E Bekelman; Andrea Denicoff; Jeffrey Buchsbaum
Journal: J Clin Oncol Date: 2018-07-09 Impact factor: 44.544

2. Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.

Authors: Grace L Smith; Patricia A Ganz; Justin E Bekelman; Steven J Chmura; James J Dignam; Jason A Efstathiou; Reshma Jagsi; Peter A Johnstone; Michael L Steinberg; Stephen B Williams; James B Yu; Anthony L Zietman; Ralph R Weichselbaum; Ya-Chen Tina Shih
Journal: Int J Radiat Oncol Biol Phys Date: 2016-11-08 Impact factor: 7.038

3. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.

Authors: Hubert Y Pan; Jing Jiang; Karen E Hoffman; Chad Tang; Seungtaek L Choi; Quynh-Nhu Nguyen; Steven J Frank; Mitchell S Anscher; Ya-Chen Tina Shih; Benjamin D Smith
Journal: J Clin Oncol Date: 2018-03-21 Impact factor: 44.544

Review 4. Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.

Authors: Nikhil T Sebastian; Meng Xu-Welliver; Terence M Williams
Journal: J Thorac Dis Date: 2018-08 Impact factor: 2.895

Review 5. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.

Authors: Sophia C Kamran; Jay O Light; Jason A Efstathiou
Journal: Prostate Cancer Prostatic Dis Date: 2019-04-09 Impact factor: 5.554

6. A 20-Year Analysis of Clinical Trials Involving Proton Beam Therapy.

Authors: Bismarck C L Odei; Dustin Boothe; Sameer R Keole; Carlos E Vargas; Robert L Foote; Steven E Schild; Jonathan B Ashman
Journal: Int J Part Ther Date: 2017-03-14

Review 7. [Progress on the Therapeutic Approaches for Malignant Tumor  with Superior Vena Cava Syndrome].

Authors: Xiangzheng Liu; Shijie Zhang; Jian Li
Journal: Zhongguo Fei Ai Za Zhi Date: 2016-11-20

8. Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.

Authors: Justin E Bekelman; Hien Lu; Stephanie Pugh; Kaysee Baker; Christine D Berg; Amy Barrington de González; Lior Z Braunstein; Walter Bosch; Cynthia Chauhan; Susan Ellenberg; L Christine Fang; Gary M Freedman; Elizabeth A Hahn; B G Haffty; Atif J Khan; Rachel B Jimenez; Christy Kesslering; Bonnie Ky; Choonsik Lee; Hsiao-Ming Lu; Mark V Mishra; C Daniel Mullins; Robert W Mutter; Suneel Nagda; Mark Pankuch; Simon N Powell; Fred W Prior; Karen Schupak; Alphonse G Taghian; J Ben Wilkinson; Shannon M MacDonald; Oren Cahlon
Journal: BMJ Open Date: 2019-10-15 Impact factor: 2.692

Review 9. Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.

Authors: Robert W Mutter; J Isabelle Choi; Rachel B Jimenez; Youlia M Kirova; Marcio Fagundes; Bruce G Haffty; Richard A Amos; Julie A Bradley; Peter Y Chen; Xuanfeng Ding; Antoinette M Carr; Leslie M Taylor; Mark Pankuch; Raymond B Mailhot Vega; Alice Y Ho; Petra Witt Nyström; Lisa A McGee; James J Urbanic; Oren Cahlon; John H Maduro; Shannon M MacDonald
Journal: Int J Radiat Oncol Biol Phys Date: 2021-05-25 Impact factor: 8.013

Review 10. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome.

Authors: Christopher Straka; James Ying; Feng-Ming Kong; Christopher D Willey; Joseph Kaminski; D W Nathan Kim
Journal: Springerplus Date: 2016-02-29

Review 4. Stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances.

Review 5. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.

Review 7. [Progress on the Therapeutic Approaches for Malignant Tumor with Superior Vena Cava Syndrome].

Review 9. Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.

Review 10. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome.

Review 7. [Progress on the Therapeutic Approaches for Malignant Tumor  with Superior Vena Cava Syndrome].